Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (27)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Evert, M.
Right arrow Articles by Dombrowski, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Evert, M.
Right arrow Articles by Dombrowski, F.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Carcinogenesis, Vol. 23, No. 5, 697-703, May 2002
© 2002 Oxford University Press


ACCELERATED PAPER

Morphology and morphometric investigation of hepatocellular preneoplastic lesions and neoplasms in connexin32-deficient mice

Matthias Evert1, Thomas Ott2, Achim Temme2, Klaus Willecke2 and Frank Dombrowski1,3

1 Institut für Pathologie, Otto-von-Guericke-Universität, Magdeburg, Germany and
2 Institut für Genetik, Rheinische Friedrich-Wilhelms-Universität, Bonn, Germany

Gap junctions are composed of protein subunits, called connexins, and provide a pathway for the exchange of ions and small molecules between contacting cells. This transfer of molecules is thought to be an important pathway for direct cell communication, and is involved in tissue homeostasis, growth control and embryonic development. Impairment of gap junctional intercellular communication (GJIC) via different mechanisms may therefore contribute to dysregulated cellular proliferation and subsequent tumor development. We investigated the effect of Connexin32-deficiency on liver histology and the formation of preneoplastic foci and hepatocellular neoplasms in transgenic knockout mice, as Connexin32 (Cx32) is the major gap junction protein in the liver. Loss of Cx32 does not alter the morphology of extrafocal liver tissue. However, after administration of a single dose of diethylnitrosamine (DEN), given 2 weeks after birth, the number and volume fraction of preneoplastic foci showed a 3.3-fold to 12.8-fold increase in the Cx32-deficient mice as compared with the corresponding wildtype groups, regardless of sex and age of the animals. Number and volume fraction of hepatocellular adenomas and carcinomas also increased significantly in these animals. The experimental groups did not differ in the morphology of the different types of preneoplastic foci and neoplasms. On the other hand, Cx32-deficiency without DEN treatment did not lead to an increase in the spontaneous development of any type of preneoplastic hepatic foci or hepatocellular neoplasms in up to 18-month-old Cx32-deficient mice as compared with wildtype controls. In conclusion, our results indicate that impairment of GJIC in mouse liver due to deletion of the Cx32 coding DNA clearly promotes the carcinogenic effect of DEN administration and results in a higher susceptibility to hepatocellular neoplasms, but does not appear to initiate hepatic tumor development.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Toxicol SciHome page
P. Marx-Stoelting, J. Mahr, T. Knorpp, S. Schreiber, M. F. Templin, T. Ott, A. Buchmann, and M. Schwarz
Tumor Promotion in Liver of Mice with a Conditional Cx26 Knockout
Toxicol. Sci., June 1, 2008; 103(2): 260 - 267.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
N. Hokaiwado, M. Asamoto, K. Ogawa, and T. Shirai
Transgenic Disruption of Gap Junctional Intercellular Communication Enhances Early but Not Late Stage Hepatocarcinogenesis in the Rat
Toxicol Pathol, October 1, 2005; 33(6): 695 - 701.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
L. M. Hix, D. A. Frey, M. D. McLaws, M. Osterlie, S. F. Lockwood, and J. S. Bertram
Inhibition of chemically-induced neoplastic transformation by a novel tetrasodium diphosphate astaxanthin derivative
Carcinogenesis, September 1, 2005; 26(9): 1634 - 1641.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Evert, J. Sun, S. Pichler, N. Slavova, R. Schneider-Stock, and F. Dombrowski
Insulin Receptor, Insulin Receptor Substrate-1, Raf-1, and Mek-1 during Hormonal Hepatocarcinogenesis by Intrahepatic Pancreatic Islet Transplantation in Diabetic Rats
Cancer Res., November 1, 2004; 64(21): 8093 - 8100.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
T. J. King and P. D. Lampe
The Gap Junction Protein Connexin32 Is a Mouse Lung Tumor Suppressor
Cancer Res., October 15, 2004; 64(20): 7191 - 7196.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
T. J. King and P. D. Lampe
Mice deficient for the gap junction protein Connexin32 exhibit increased radiation-induced tumorigenesis associated with elevated mitogen-activated protein kinase (p44/Erk1, p42/Erk2) activation
Carcinogenesis, May 1, 2004; 25(5): 669 - 680.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
M. L. Z. Dagli, H. Yamasaki, V. Krutovskikh, and Y. Omori
Delayed liver regeneration and increased susceptibility to chemical hepatocarcinogenesis in transgenic mice expressing a dominant-negative mutant of connexin32 only in the liver
Carcinogenesis, April 1, 2004; 25(4): 483 - 492.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
J. C. SAEZ, V. M. BERTHOUD, M. C. BRANES, A. D. MARTINEZ, and E. C. BEYER
Plasma Membrane Channels Formed by Connexins: Their Regulation and Functions
Physiol Rev, October 1, 2003; 83(4): 1359 - 1400.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
J. M. Rukstalis, A. Kowalik, L. Zhu, D. Lidington, C. L. Pin, and S. F. Konieczny
Exocrine specific expression of Connexin32 is dependent on the basic helix-loop-helix transcription factor Mist1
J. Cell Sci., August 15, 2003; 116(16): 3315 - 3325.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.